Alpha DNA Investment Management’s Axos Financial AX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,818
Closed -$531K 206
2024
Q1
$531K Buy
+9,818
New +$517K 0.2% 124
2023
Q3
Sell
-19,448
Closed -$767K 175
2023
Q2
$767K Sell
19,448
-8,108
-29% -$314K 0.26% 116
2023
Q1
$1.02M Buy
+27,556
New +$1.19M 0.3% 114
2021
Q2
Sell
-31
Closed -$1K 146
2021
Q1
$1K Buy
+31
New +$1.4K ﹤0.01% 606

Other funds holding AX

Alpha DNA Investment Management's AX Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Axos Financial (AX) in Q2 2024, closing a stake of 9,818 shares — an estimated $531K sold.

Alpha DNA Investment Management first reported a position in AX in Q1 2021 and held it in 4 quarters. The position peaked at $1.02M in Q1 2023. 318 funds tracked by Wall St. Rank hold AX as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Axos Financial position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,818 Axos Financial shares in Q2 2024, an estimated $531K.
  • Alpha DNA Investment Management first reported a position in Axos Financial in Q1 2021 and held it in 4 quarters.
  • Alpha DNA Investment Management's Axos Financial position peaked at $1.02M in Q1 2023.
  • 318 funds tracked by Wall St. Rank held Axos Financial as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.